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ABSTRACT
This review evaluates the current understanding of research on the impact of physical
activity in the prevention of colorectal cancer. Current biological mechanisms implicated
in physical activity and colorectal cancer risk reduction are blood glucose regulation,
insulin sensitivity, leptin and adiponectin profiles, inflammation as well as secreted
protein acidic and rich in cysteine (SPARC), an exercise induced myokine. Recent
literature indicates that 30-60 minutes of moderate to vigorous activity a day is effective
against colorectal cancer development, and there is convincing evidence of aerobic
exercise as differently beneficial in recruiting mechanisms identified as preventative
against colorectal cancer. This article provides a critical review of the evidence-based
literature concerning the benefits of physical activity in reducing the risk for colorectal
cancer. Further well designed animal and clinical trials testing differing exercise
protocols are recommended for future research to enable better understanding of the
currently implicated mechanisms in colorectal cancer development.
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CHAPTER 1
INTRODUCTION
According to the American Cancer Society’s 2013 statistics, colorectal cancer is
the third most prevalent cancer among men and women in the United States. Despite
mortality rates declining in the population over 50 years of age, rates of colorectal cancer
incidence in individuals under 50 years of age are on the rise. The etiology of colorectal
cancer is a complex phenomenon that involves the interaction of genetic and
environmental factors.

However, the vast majority of cases can be ascribed to

environmental causes as they account for more than 80% of all incidences 1. Physical
inactivity has emerged as a leading environmental risk factor for colorectal cancer.
According to the World Health Organization (WHO), physical inactivity is the fourth
leading risk for mortality globally; it is responsible for 6% of all deaths worldwide. In
fact, physical inactivity raises the risk for numerous chronic diseases such as heart
disease

2-6

, diabetes

7-11

and various cancers including colorectal cancer

inactivity is thought to account for 13-14% of all colorectal cancer cases

12-17

18

.

. Physical
Thus, the

American Cancer Society speculates that the increase in colorectal cancer incidence
among the younger population is, at least in part, due to a sedentary lifestyle. Conversely,
physical activity or exercise training has been linked to a reduced risk for colorectal
cancer; epidemiological studies indicate an inverse association between physical activity
and colorectal cancer risk and controlled experiments in mice substantiate these claims.
While there is an abundance of data to support a link between physical activity and

1

colorectal cancer risk, the mechanisms responsible for this relationship have not yet been
fully elucidated.
Possible mechanisms that link physical activity to reduced colorectal cancer risk
have been investigated using epidemiological studies as well as controlled experimental
studies in mice. Mouse models that recreate the colorectal cancer development seen in
humans have been particularly useful in examining the benefits of exercise on colorectal
cancer risk in a controlled setting (i.e the dose of exercise can be controlled). For
example, the ApcMin/+ mouse that develops intestinal colon polyps similar to an
aggressive case of human colorectal cancer has been widely used in exercise studies.
Also, carcinogens that induce colorectal cancer including azoxymethane, (AOM) and 1,2dimethyl hydrazine, (DMH) have been utilized to investigate the effects of exercise on
colorectal cancer in both mice and rats.

To date, the mechanisms that have been

implicated in the benefits of physical activity on colorectal cancer risk include insulin
regulation, leptin and adiponectin profiles, inflammatory processes as well as secreted
protein acidic and rich in cysteine (SPARC), an exercise induced myokine. This review
will examine the recent literature on the aforementioned mechanisms that are thought to
link physical activity to reduced colorectal cancer risk.

2

CHAPTER 2
METABOLIC MEDIATORS
Metabolic mediators control growth and development, regulate energy output and
storage, and work to maintain healthy body mass. Imbalances in their concentrations have
been linked to a heightened risk for colorectal cancer.
2.1 INSULIN
Insulin is a hormone produced by beta cells in the pancreas; it functions to
regulate blood glucose levels.

Evidence indicates that insulin resistance and its

associated pathological conditions including elevated fasting glucose and insulin are
implicated in colorectal cancer 19. Risk factors for colorectal cancer, including obesity,
physical inactivity and type 2 diabetes are all linked to insulin resistance and
hyperinsulinemia

20,21,22,23,24

. While epidemiological evidence only indirectly associates

insulin with colorectal cancer risk, strong evidence implicates insulin as player in
colorectal cancer. For example, insulin injections have been reported to enhance the
growth of aberrant crypt foci as well as increase the number and size of colorectal
tumors2526. Similarly, in vivo evidence supports a tumor promoting role of insulin on
colorectal cancer cells

27,28,29,30

. Alterations in insulin may play a role in the benefits of

exercise on the development of colorectal cancer. It is well recognized that exercise can
decrease hyperinsulinemia. For example, in a study of one hundred Type 2 diabetic
obese or overweight subjects, exercise was successful at reducing plasma insulin levels.

3

Within this high-risk population, a significant decrease in plasma insulin levels across all
exercise modalities was reported.

The greatest effect was seen in those subjects

performing aerobic training in conjunction with resistance training 31. To date, there is no
direct evidence linking exercise to the prevention of colorectal cancer via a reduction in
insulin levels. However, lowering baseline serum levels of insulin through exercise
would presumably attenuate insulin’s well-documented effects on colorectal cancer
development.
2.2 INSULIN GROWTH FACTOR 1
Insulin-like growth factors (IGF-I and IGF-II) and their binding proteins (IGFBP1 and IGFBP-6) have been linked to colorectal cancer risk in epidemiological studies as
well as controlled experimental studies in mice

32,33

. IGFs promote proliferation and

survival of a wide range of cell types and are thus critical for normal development.
However, dysregulation of the IGF system has been implicated in a range of diseases
including colorectal cancer.

For example, epidemiological studies have shown that

higher circulating IGF levels are associated with increased risk for colorectal cancer

34

.

This relationship is supported by controlled experimental studies in mice; colorectal
cancer growth is decreased in mice following deletion of the IGF1 gene

35

. In vitro

studies have documented that the IGF-1 receptor facilitates malignant transformation of a
number of oncogenes

36

. And there is an abundance of literature to support the role of

IGF-1 on promotion of survival, proliferation, migration and invasion of many cell types.
For example, in vitro IGF-1 promotes cell cycle progression and inhibition of apoptosis
in several colonic adenocarcinoma cell lines 37, 29.

4

Exercise training has been shown to influence IGF levels, which may be a
potential mechanism for the benefits of exercise on colorectal cancer. However, the
dynamics of this relationship is likely heavily influenced by the intensity, mode and
duration of the training regime. Several studies suggest that initiation of a training
program, which is associated with a substantial increase in energy expenditure, leads
initially to decreases in IGF levels. Conversely, following adaptation to the training the
suppression of IGF is diminished and in fact IGF may exceed the pre-training levels.
Therefore, the relationship between exercise and IGF is potentially very complex, which
likely explains the inconsistent findings on its potential in the literature. For example,
one study reported that voluntary wheel running exercise was associated with a lower
polyp number in Apcmin mice but the exercise group actually showed higher IGF-1 levels;
although there was no association between polyp number and IGF reported

38

. Contrary

to those findings, recent literature has shown that IGF-1 levels are slightly lowered (~9%)
a carcinogenic mouse model (AOM/DSS) of colorectal cancer following voluntary
exercise 39. However, the decrease was only significantly correlated with the lower colon
tumor formation in AOM/DSS-treated mice when the associated increasing IGFBP-3
levels were considered 39. Ju et al hypothesized a lower molar ratio of IGF-1 to IGFBP 3 (IGF binding protein) was responsible for inhibiting tumor growth in these mice

39

.

Although studies in animal literature support a positive effect of exercise on IGF-1 in
colorectal cancer, the evidence has been mixed, possibly due to the complex nature of
IGF-1’s interactions with a number of other contributing factors as well as the diversity
of exercise protocols used in these studies. More research detailing IGF-1’s responses to
exercise are needed to formulate a better evidence base within the mouse model. To date,

5

there are no clinical studies on the effects of exercise on IGF-1 in colorectal cancer, this
is likely due, at least in part, to the conflicting evidence foundation in the animal
literature.
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CHAPTER 3
ADIPOKINES

Adipose-derived hormones (adipokines), along with their customary role in
energy homeostasis, have been identified as potential mediators of the effects of exercise
on colorectal cancer risk.
3.1 LEPTIN
Leptin is a long-term regulator of energy expenditure and food intake. Leptin has
been shown to stimulate intestinal oncogenesis through a variety of signaling pathways 40.
The hypothesized link between leptin and colorectal cancer was driven initially by reports
of leptin receptor expression by various human epithelial colon cancer cell lines. When
bound to leptin, the receptor can activate signal transduction pathways that can enhance
cell proliferation and DNA synthesis.

For example, Fenton et al., reported that leptin

promotes the proliferation of preneoplastic (IMCE) cells

41

. While the in vitro evidence

is relatively strong, there are mixed reports among the animal studies. A recent study
found a significant decrease of tumor cell proliferation in leptin-deficient tumors, as well
as a dramatic inhibition of tumor growth in leptin-deficient and leptin-receptor-deficient
mice 42. Whereas a previous study reported that leptin failed to promote growth of colon
cancer xenografts in nude mice and did not increase intestinal tumorigenesis in ApcMin/+
mice 43. Clinical investigations have reported that a progressive increase in leptin occurs
during colorectal carcinogenesis 44. Taken together, the available literature suggests that
lowering baseline levels of leptin could lower risk for developing colorectal cancer. It
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has been shown that exercise can significantly reduce baseline leptin levels in APC
mice

45

Min

. However, it is important to note that while small changes were seen in male

polyp development, no decrease in female mice tumor load was observed; therefore, the
relevance of these findings are inconclusive.

Follow up studies by Colbert et al

demonstrated that a greater frequency and duration of voluntary wheel running decreased
male polyp count by 25%, but in those studies, energy balance, rather than leptin was the
mechanism investigated

38

. Citing Colbert et al’s decision to conclude investigating

leptin mechanistically after their first study, it can be presumed that although dated
animal research found that exercise was effective in lowering baseline leptin levels,
current research does not support a leptin mediated link between exercise and colorectal
cancer prevention. However, it is important to note that the observed decrease in leptin
with exercise, independent of colorectal cancer, is likely due to the exercise-induced
decrease in fat mass.
3.2 ADIPONECTIN
Adiponectin (APN) is an adipokine secreted exclusively by adipose tissue, which
has been reported to be negatively associated with colorectal cancer risk; a decrease in
adiponectin is associated with increased risk for colorectal cancer. Adiponectin’s
suppressive role in tumorigenesis has been widely documented in mouse models of
colorectal cancer

46,47

. More recent animal studies have used APN deficiency models to

mechanistically determine its role in both the risk and development of colorectal cancer.
For example, Saxena et al reported that APN deficiency was associated with higher
expressions of pro-inflammatory and pro-cancerous markers

48

. Further, APN knockout

mice showed greater tumor numbers as well as greater tumor area due to an increase in

8

colonic mucosal erosion that resulted from a thinning of the mucosal lining

49

. Another

study examined the role of APN in a carcinogenic as well as a genetic mouse model of
colorectal cancer. It was found that deficiency of APN increased tumorigenesis in both
models; in the Apcmin/+ mouse model APN-/- increased tumorigenesis by 3.2 fold and in
the carcinogenic model by ~70% 50.
Several studies have examined the benefits of exercise on APN in the settings of
colorectal cancer. To date, Saxena et al has reported the most promising data to support
the protective effects of exercise on colorectal cancer development.

They report

increased serum levels of APN by exercise training and suggest that it may be one of the
mechanisms for the protective role of exercise of inflammatory processes in a
carcinogenic mouse model of colitis.

51

. As expected, their APN deficient mice were

more susceptible to inflammation than their wild-type counterparts and the benefits of
exercise on inflammation were lost in their APN deficient mice. Other studies have
demonstrated similar effects of exercise on APN levels. Tang et al noted a particularly
interesting shift of APN levels in rats in response to exercise. High fat diet feedings for 8
weeks decreased circulating APN levels; however, 8 weeks of exercise training reversed
this effect

52

. Such results prove promising for prompting additional studies to improve

our understanding of the effects of exercise on adiponectin in the settings of colorectal
cancer.
As with the animal literature, higher levels of APN have been implicated in
having a protective role in the development of human colorectal cancer. For example, an
inverse relationship between serum APN and colorectal cancer grade was observed in a
recent case study involving subjects diagnosed with colorectal cancer

9

53

. Further, the

benefits of exercise on APN have also been investigated, although not in the settings of
colorectal cancer. To date, few clinical trials have investigated the specific effects of
exercise on APN levels. This is presumably due to the fact that the effect of exercise on
circulating APN levels varies by individual; this may be attributed to variances in genes
or environmental factors

54

. A study by Lee et al sought to understand the activity of

APN polymorphisms and completed a study on obese women having variations of two
polymorphisms of the APN gene that are reported to be associated with insulin resistance
and APN levels

55

. They found that regardless of polymorphism, aerobic training over 3

months increased circulating APN levels

56

. Because studies in mouse models have

reported that an increase in APN levels decreases polyp development and load,
presumably these subjects would have attenuated risk for colorectal cancer given the
exercise-induced increase in APN. In addition, these individuals had a significant
decrease in body weight, BMI, and waist circumference, which would also mitigate their
risk of developing colorectal cancer. Although the clinical literature available seems
promising, further clinical studies are needed to confirm the link between exercise,
adiponectin and the development of colorectal cancer outside the animal model.
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CHAPTER 4
INFLAMMATION

The colon has evolutionarily outfit itself with a large population of
immunologically active cells to defend the body against invasion and to regulate
homeostasis

57

. It is through their modulation that the release of inflammatory cytokines

is regulated

58

. If, over time, these cells are constantly expressing higher than normal

levels of these inflammatory cytokines it can lead to chronic intestinal inflammation. It
has been hypothesized not only that colorectal cancer pathogenesis may be influenced by
the state of this chronic intestinal inflammation

59

, but also that regular exercise is

capable of mitigating it.
4.1 TNF ALPHA
TNF-α is a cytokine involved primarily with systemic inflammation. Its effector
cells (immune cells) regulate the inflammatory response to a number of different assaults
and through initiation of a variety of inflammatory cascades. TNF-α has been found to be
a main stimulant of colitis-associated colorectal cancer 59. The most likely mechanism for
this response is that TNF-α elevates the activity of inflammation-sensitive transcription
factors such as NF-κB

60

as well as the inflammatory cytokines IL-6 and IL-1β

61

. We

have shown that TNF-α mRNA expression is increased in the intestines of the ApcMin/+
mouse, which is associated with the abundance of large polyps

62

. Further, using a

monocyte chemoattractant protein 1 (MCP-1) knockout mouse we have reported a
decrease in the number of macrophages in the polyp tissue, which was linked to a
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reduction in TNF-α expression

63

.

This is of particular importance given that the

predominant expression of TNF-α in colorectal cancer is observed within tumor
associated macrophages

64

. Direct evidence for the involvement of TNF-α in cancer

comes from observations that antibodies against TNF-α inhibit the development of
inflammation-related colon cancer 65.
While the available literature on the benefits of exercise on TNF-α in colon cancer
is limited, the studies that are presented are promising. For example, recently it has been
shown that regular exercise suppressed the generation of aberrant crypt foci in the colon
following AOM and this was associated with decreased levels of TNF-α in both the colon
and plasma

66

.

Similarly, TNF-α expression in intestinal lymphocytes of younger

C57BL/6 mice has been shown to be decreased with voluntary wheel running exercise
suggesting that long term exercise may protect the bowl by reducing intestinal
inflammation 67. Further, a recent study in aged C57BL/6 mice demonstrated that regular
exercise lowered TNF-α in plasma and serum 68. Although good evidence for a benefit of
exercise on TNF-α in colorectal cancer in animals is beginning to accumulate in the
literature, the clinical data is disappointingly sparse and relatively undocumented. Nonethe-less a team in India has demonstrated that humans respond accordingly to regular
exercise, with over 70% of subjects lowering their baseline values of TNF-alpha after one
month of moderate exercise 69.

4.2 IL 6
Interleukin-6 or (IL)-6 is a pleiotropic cytokine that modulates a variety of
physiological responses and activates genes associated with cellular proliferation,
differentiation, and apoptosis. Epidemiological studies indicate an association between
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IL-6 and colorectal cancer and controlled experiments in mice substantiate these claims.
This effect is thought to be largely mediated through its ability to increase intestinal
inflammation

70

. A recent study reported that IL-6 expression in stage III colon cancer

patients is a prognostic marker of tumor behavior

71

. Further, using IL-6 knockout mice

as well as IL-6 overexpression techniques, Baltgalvis et al., eloquently examined the role
of IL-6 on tumor characteristics in the ApcMin/+ mouse model of colon cancer. They
reported that knocking out IL-6 reduced the number of large polyps by approximately
30% and these effects were reversed when IL-6 was overexpressed 72. Interestingly, they
also demonstrate that IL-6 is necessary for the onset of adipose and skeletal muscle
wasting in the ApcMin/+ mouse as IL-6-/- mice did not lose gastrocnemius muscle mass or
epididymal fat pad mass while IL-6 overexpression led to a decrease in mass for each of
these tissues.
IL-6 has been implicated in the link between exercise and colorectal cancer;
several studies have reported a benefit of exercise on IL-6 in colorectal cancer. One
study reported that nine weeks of moderate treadmill running decreased total intestinal
polyps by 29% in male ApcMin/+ mouse and this was associated with a 98% decrease in
IL-6

73

. A follow up study by the same group documented that moderate-intensity

treadmill exercise can attenuate IL-6-dependent cachexia in ApcMin/+ mice, independent
of changes in IL-6 concentration and muscle inflammatory signaling

74

. The exercise

effect was associated with improved insulin sensitivity and improved energy status in the
muscle. Similarly, IL-6 induced mitochondrial remodeling and proteolysis was
documented to be rescued with moderate exercise training even in the presence of high
circulating IL-6 levels

75

. While there is good evidence to support an effect of exercise

13

on IL-6 in mouse models of colorectal cancer, there is very little clinical evidence in this
area. Although given the well documented effects of moderate exercise training on
reducing IL-6, it is likely that these same outcomes will be seen in the human literature.
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CHAPTER 5
SPARC

It has been postulated that the exercise-induced production of novel myokines can
alter the mechanisms involved in colorectal cancer pathogenesis. In a recent study, Aoi
et al. suggested that the anti-tumor effect of regular exercise was more dependent on
circulating factors rather than endogenous proteins in the colon

66

. One such myokine,

secreted protein acidic and rich in cysteine (SPARC) also known as osteonectin, is a
matricellular protein that is involved in cell to cell interaction, growth factor function and
cell differentiation 76. A recent study by Aoi et al examined the effects of exercise on the
expression of this novel myokine in the muscle of mice and humans following a single
bout of exercise. It was found that a single bout of aerobic exercise increased plasma
levels of SPARC in both humans and mice via promotion of SPARC upregulation in
contracting myocytes

77

. Although SPARC returned to baseline levels after 6 hours in

humans, their studies demonstrate that regular exercise enhanced the secretory ability of
SPARC in response to muscle contraction by increasing the amount of SPARC in resting
muscle tissue 77. Using SPARC knockout mice, they went on to examine if the benefits
of exercise on colorectal cancer may be mediated by SPARC. They found that lowintensity exercise reduced aberrant crypt foci growth in a chemically-induced mouse
model of colorectal cancer. However, the benefits of exercise were lost in SPARC
deficient mice implicating a role of SPARC on the benefits of exercise in colorectal
cancer. Further, exercise enhanced apoptosis in colon mucosal cells but again these

15

effects were not evident in SPARC deficient mice. These recent findings concerning upregulation of SPARC via aerobic exercise provide yet another outlet to investigate the
promising effects of exercise in prevention of colorectal cancer. Further studies are
needed to better elucidate SPARC’s effects on the known mechanisms of colorectal
pathogenesis.
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CHAPTER 6
PHYSICAL ACTIVITY AND EXERCISE RECOMMENDATIONS
Physical activity (PA) is defined by the American College of Sports Medicine as
any bodily movement created from muscle contraction and resulting in an energy
expenditure increase over that of resting energy expenditure (REE).

Exercise is a

planned and structured form of PA that uses repetitive bodily movement to improve or
maintain one or more components of physical fitness, which are simply characteristics
that allow one to perform physical activities.
The World Health Organization’s Global Recommendations on Physical Activity
for Health (2008) focus mainly on type, duration, frequency, intensity, and volume of
physical activity. These recommendations are minimum guidelines allotted to provide
benefits in cardiorespiratory health, metabolic health, bone health, depression and breast
and colon cancer. WHO recommends at least 150 minutes of moderate intensity aerobic
physical activity or at least 75 minutes of vigorous physical activity per week. WHO’s
guidelines also note that at least 30-60 minutes per day of moderate to vigorous activity is
needed to observe significantly lower risks of breast and colon cancer 78.
While epidemiological data suggested higher durations of physical activity is
protective against colorectal cancer, the early animal literature was inconclusive. Colbert
et al noted that while prior epidemiological studies and studies in chemically induced
cancerous rats concluded a beneficial influence of exercise on tumor polyp load, their
2002 work provided limited evidence for possible preventative effects against intestinal

17

tumorigenesis in male Apcmin/+ mice, and no evidence for an effect in female
Apcmin/+ mice

45

. Subsequently, advances in exercise protocols as well as additional

investigation into pivotal mechanisms surrounding the development of colorectal cancer
have established a dose-response relationship supporting the suppressive nature of
exercise on colorectal cancer.
Recent studies by Colbert et al with C57BL/6J-ApcMin mice reported that
voluntary treadmill running and the negative energy balance resulting from pair-feeding
with a non-exercising control group decreased polyp number in a dose dependent manner
in the running group. The running group also maintained a significantly smaller overall
body weight than the control group 38. Similarly, another study reported that forced lowintensity running and forced swimming reduced aberrant crypt foci, precursors to colonic
adenocarcinomas, sustained from carcinogenic DMH-injections in rats

79,80

.

More

recently, in mice subjected to azoxymethane (AOM) injections, a tri-weekly running
schedule for six weeks decreased aberrant crypt foci development compared to a
sedentary treatment 66.
While there is ample evidence to support a lower incidence of colorectal cancer
development in animal models with higher levels of aerobic exercise, the clinical data
supporting such a link is scarce by comparison. However, McTiernan et al, found a 12month exercise intervention of 60 minutes per day 6 days a week decreased colonic crypt
cell proliferation in healthy human subjects

81

. Because an increased cell proliferation

rate and an extension of the normal proliferative zone within the colon crypt are
reversible precursors of colonic neoplasia

82

, these subjects, having lowered their

proliferation rates, would have attenuated their risk for developing colorectal cancer.
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Likewise, a 2011 meta-analysis of 20 clinical studies of physical activity and colonic
polyps by Wolin et al concluded a significant inverse relation between physical activity
and colon adenomas or polyps. Wolin et al conclude that physical activity may reduce
the risk of colon polyp development by 15%. The reduction of risk by physical activity
may also be substantially greater for large and advanced polyps 83. Recent cohort studies
also mirror animal and clinical findings on the positive role of physical activity on colon
cancer risk. A 2012 screening study of 912 multi-ethnic persons scheduled for an exam
concluded that more than 60 minutes of exercise a week, was correlated with a low or no
polyp count. Subjects who performed at least 60 minutes of exercise weekly were less
likely to have any detectable polyps compared to those who did not regularly exercise.
They were also less likely to have an adenoma on their colonoscopy compared to their
counterparts with more sedentary lifestyles

84

. The questions in the study pertaining to

exercise were asked in a manner that inferred activity outside daily activity, i.e. exercise.
Unfortunately, mode of exercise was not investigated in this study.
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CHAPTER 7
CONCLUSION
The current body of evidence supports a positive effect of exercise, and in
particular vigorous aerobic activity, on the prevention of colorectal cancer. Animal
studies support the hypothesis that exercise mediates this protective effect by inducing
changes in blood glucose regulation, insulin sensitivity, the adiponectin profile,
inflammation regulation and SPARC secretion. For a better understanding of these
mechanisms and their role in preventing tumorigenesis, further studies containing even
more exercise protocol variations should be completed. Granted the scarcity of current
clinical data, future clinical studies are needed to support the conclusions of these animal
studies. Further advancements within this field are important for public health prevention
practices and awareness that may aid in nudging the population towards healthier lifestyle
choices.
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